A case of recurrent chronic eosinophilic pneumonia after switching from benralizumab to dupilumab
Dupilumab inhibits interleukin-4Rα and suppresses type 2 inflammation. Careful administration of dupilumab is required because it increases the blood eosinophil count secondary to a decrease in local eosinophil counts, sometimes resulting in eosinophilic complications. We herein report a case of rec...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2024-01-01
|
| סדרה: | Respiratory Medicine Case Reports |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2213007123001636 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|